Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H W Verspaget

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Gastroenterology|June 1, 1995
Plasminogen activation system and colorectal cancer biologyH W Verspaget
BMJ (Clinical Research Ed.)|April 29, 1998
Proteases as prognostic markers in cancerH W Verspaget
Advances in Experimental Medicine and Biology|January 1, 1995
Effects of mesalazine on lamina propria white cell functionsH W Verspaget
Alimentary Pharmacology & Therapeutics|November 28, 2002
Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease--radicals or ridiculous?L Kruidenier, H W Verspaget
Mediators of Inflammation|August 15, 1998
Antioxidants and mucosa protectives: realistic therapeutic options in inflammatory bowel disease?L Kruidenier, H W Verspaget
Drugs|October 20, 1998
The future role of anti-tumour necrosis factor-alpha products in the treatment of Crohn's diseaseR A van Hogezand, H W Verspaget
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1997
New therapies for inflammatory bowel disease: an update on chimeric anti-TNF alpha antibodies and IL-10 therapyR A van Hogezand, H W Verspaget
The Netherlands Journal of Medicine|February 1, 1996
Selective immunomodulation in patients with inflammatory bowel disease--future therapy or reality?R A van Hogezand, H W Verspaget
Alimentary Pharmacology & Therapeutics|June 1, 1988
Inhibition of intestinal macrophage chemotaxis to leukotriene B4 by sulphasalazine, olsalazine, and 5-aminosalicylic acidO H Nielsen, H W Verspaget, J Elmgreen
Clinical Neurology and Neurosurgery|January 1, 1992
Copper-zinc superoxide dismutase in cerebrospinal fluid: implications for oxygen-radical stress in the central nervous systemP M Laboyrie, R A Roos, H W Verspaget
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Gastroenterology|June 1, 1995
Plasminogen activation system and colorectal cancer biologyH W Verspaget
BMJ (Clinical Research Ed.)|April 29, 1998
Proteases as prognostic markers in cancerH W Verspaget
Advances in Experimental Medicine and Biology|January 1, 1995
Effects of mesalazine on lamina propria white cell functionsH W Verspaget
Alimentary Pharmacology & Therapeutics|November 28, 2002
Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease--radicals or ridiculous?L Kruidenier, H W Verspaget
Mediators of Inflammation|August 15, 1998
Antioxidants and mucosa protectives: realistic therapeutic options in inflammatory bowel disease?L Kruidenier, H W Verspaget
Drugs|October 20, 1998
The future role of anti-tumour necrosis factor-alpha products in the treatment of Crohn's diseaseR A van Hogezand, H W Verspaget
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1997
New therapies for inflammatory bowel disease: an update on chimeric anti-TNF alpha antibodies and IL-10 therapyR A van Hogezand, H W Verspaget
The Netherlands Journal of Medicine|February 1, 1996
Selective immunomodulation in patients with inflammatory bowel disease--future therapy or reality?R A van Hogezand, H W Verspaget
Alimentary Pharmacology & Therapeutics|June 1, 1988
Inhibition of intestinal macrophage chemotaxis to leukotriene B4 by sulphasalazine, olsalazine, and 5-aminosalicylic acidO H Nielsen, H W Verspaget, J Elmgreen
Clinical Neurology and Neurosurgery|January 1, 1992
Copper-zinc superoxide dismutase in cerebrospinal fluid: implications for oxygen-radical stress in the central nervous systemP M Laboyrie, R A Roos, H W Verspaget
Pageof 16